nodes	percent_of_prediction	percent_of_DWPC	metapath
Nicardipine—ABCB1—melanoma	0.159	1	CbGaD
Nicardipine—CYP2E1—Dacarbazine—melanoma	0.072	0.257	CbGbCtD
Nicardipine—CYP3A4—Temozolomide—melanoma	0.052	0.186	CbGbCtD
Nicardipine—CYP2D6—Vemurafenib—melanoma	0.0448	0.16	CbGbCtD
Nicardipine—ABCB1—Dactinomycin—melanoma	0.0316	0.113	CbGbCtD
Nicardipine—CYP3A4—Vemurafenib—melanoma	0.0285	0.102	CbGbCtD
Nicardipine—CYP3A5—Docetaxel—melanoma	0.0251	0.0895	CbGbCtD
Nicardipine—ABCB1—Docetaxel—melanoma	0.0163	0.0583	CbGbCtD
Nicardipine—CYP3A4—Docetaxel—melanoma	0.00977	0.0349	CbGbCtD
Nicardipine—Disease progression—Carmustine—melanoma	0.00663	0.0486	CcSEcCtD
Nicardipine—CACNA1D—ear—melanoma	0.00569	0.0865	CbGeAlD
Nicardipine—CHRM5—skin epidermis—melanoma	0.00466	0.0709	CbGeAlD
Nicardipine—CALM2—ear—melanoma	0.00345	0.0525	CbGeAlD
Nicardipine—CALM1—ear—melanoma	0.00344	0.0523	CbGeAlD
Nicardipine—Haemorrhage intracranial—Temozolomide—melanoma	0.00341	0.025	CcSEcCtD
Nicardipine—Cerebral ischaemia—Temozolomide—melanoma	0.0029	0.0212	CcSEcCtD
Nicardipine—Deep vein thrombosis—Temozolomide—melanoma	0.0023	0.0168	CcSEcCtD
Nicardipine—Atrial fibrillation—Vemurafenib—melanoma	0.0021	0.0154	CcSEcCtD
Nicardipine—CALM2—endothelium—melanoma	0.00185	0.0282	CbGeAlD
Nicardipine—CALM1—endothelium—melanoma	0.00184	0.028	CbGeAlD
Nicardipine—CALM2—hair follicle—melanoma	0.00182	0.0277	CbGeAlD
Nicardipine—Injection site pain—Carmustine—melanoma	0.00177	0.013	CcSEcCtD
Nicardipine—CALM2—blood vessel—melanoma	0.00171	0.026	CbGeAlD
Nicardipine—CALM1—blood vessel—melanoma	0.0017	0.0258	CbGeAlD
Nicardipine—CACNB2—retina—melanoma	0.0017	0.0258	CbGeAlD
Nicardipine—CHRM5—eye—melanoma	0.00166	0.0252	CbGeAlD
Nicardipine—PDE1B—head—melanoma	0.00157	0.0239	CbGeAlD
Nicardipine—Deep vein thrombosis—Docetaxel—melanoma	0.00153	0.0112	CcSEcCtD
Nicardipine—Neck pain—Carmustine—melanoma	0.00147	0.0107	CcSEcCtD
Nicardipine—CHRM5—skin of body—melanoma	0.00144	0.022	CbGeAlD
Nicardipine—Injection site reaction—Carmustine—melanoma	0.00144	0.0105	CcSEcCtD
Nicardipine—Supraventricular tachycardia—Docetaxel—melanoma	0.00142	0.0104	CcSEcCtD
Nicardipine—Oedema peripheral—Vemurafenib—melanoma	0.00135	0.00992	CcSEcCtD
Nicardipine—PDE1A—head—melanoma	0.00132	0.02	CbGeAlD
Nicardipine—Throat sore—Docetaxel—melanoma	0.00129	0.00945	CcSEcCtD
Nicardipine—Oropharyngeal discomfort—Docetaxel—melanoma	0.00128	0.00937	CcSEcCtD
Nicardipine—Abnormal vision—Carmustine—melanoma	0.00126	0.00925	CcSEcCtD
Nicardipine—CALM2—neck—melanoma	0.00122	0.0186	CbGeAlD
Nicardipine—Abnormal vision—Temozolomide—melanoma	0.00122	0.00894	CcSEcCtD
Nicardipine—CALM1—neck—melanoma	0.00122	0.0185	CbGeAlD
Nicardipine—CHRM4—head—melanoma	0.00121	0.0183	CbGeAlD
Nicardipine—CALM3—eye—melanoma	0.00116	0.0176	CbGeAlD
Nicardipine—CALM3—retina—melanoma	0.00115	0.0174	CbGeAlD
Nicardipine—PDE1B—lymph node—melanoma	0.0011	0.0168	CbGeAlD
Nicardipine—Hot flush—Temozolomide—melanoma	0.00109	0.00795	CcSEcCtD
Nicardipine—Menopausal symptoms—Temozolomide—melanoma	0.00108	0.00788	CcSEcCtD
Nicardipine—Oropharyngeal pain—Docetaxel—melanoma	0.00102	0.00749	CcSEcCtD
Nicardipine—Myalgia—Vemurafenib—melanoma	0.00102	0.00746	CcSEcCtD
Nicardipine—Arthralgia—Vemurafenib—melanoma	0.00102	0.00746	CcSEcCtD
Nicardipine—Face oedema—Carmustine—melanoma	0.00101	0.00743	CcSEcCtD
Nicardipine—Face oedema—Temozolomide—melanoma	0.000981	0.00718	CcSEcCtD
Nicardipine—CACNB2—head—melanoma	0.000972	0.0148	CbGeAlD
Nicardipine—Infection—Vemurafenib—melanoma	0.00097	0.00711	CcSEcCtD
Nicardipine—Hypokalaemia—Carmustine—melanoma	0.000956	0.007	CcSEcCtD
Nicardipine—CHRM5—head—melanoma	0.000942	0.0143	CbGeAlD
Nicardipine—Injection site reaction—Docetaxel—melanoma	0.000925	0.00677	CcSEcCtD
Nicardipine—Hypokalaemia—Temozolomide—melanoma	0.000924	0.00677	CcSEcCtD
Nicardipine—PDE1A—lymph node—melanoma	0.000923	0.014	CbGeAlD
Nicardipine—CALM3—mammalian vulva—melanoma	0.000918	0.014	CbGeAlD
Nicardipine—Acute coronary syndrome—Bleomycin—melanoma	0.000915	0.0067	CcSEcCtD
Nicardipine—Hypotension—Vemurafenib—melanoma	0.000913	0.00668	CcSEcCtD
Nicardipine—CACNA2D1—head—melanoma	0.000912	0.0139	CbGeAlD
Nicardipine—Myocardial infarction—Bleomycin—melanoma	0.00091	0.00666	CcSEcCtD
Nicardipine—CALM2—eye—melanoma	0.000908	0.0138	CbGeAlD
Nicardipine—CALM1—eye—melanoma	0.000904	0.0138	CbGeAlD
Nicardipine—CALM2—retina—melanoma	0.0009	0.0137	CbGeAlD
Nicardipine—CALM1—retina—melanoma	0.000896	0.0136	CbGeAlD
Nicardipine—Musculoskeletal discomfort—Vemurafenib—melanoma	0.00089	0.00652	CcSEcCtD
Nicardipine—Haematuria—Bleomycin—melanoma	0.000885	0.00648	CcSEcCtD
Nicardipine—ADRA1B—head—melanoma	0.000861	0.0131	CbGeAlD
Nicardipine—Sweating increased—Temozolomide—melanoma	0.000855	0.00626	CcSEcCtD
Nicardipine—CACNA1D—head—melanoma	0.000849	0.0129	CbGeAlD
Nicardipine—ADRA1D—head—melanoma	0.000842	0.0128	CbGeAlD
Nicardipine—Constipation—Vemurafenib—melanoma	0.000835	0.00612	CcSEcCtD
Nicardipine—Hypoaesthesia—Bleomycin—melanoma	0.000829	0.00607	CcSEcCtD
Nicardipine—Pollakiuria—Temozolomide—melanoma	0.000811	0.00594	CcSEcCtD
Nicardipine—Erectile dysfunction—Temozolomide—melanoma	0.000808	0.00592	CcSEcCtD
Nicardipine—CALM2—skin of body—melanoma	0.00079	0.012	CbGeAlD
Nicardipine—CALM1—skin of body—melanoma	0.000787	0.012	CbGeAlD
Nicardipine—CACNA1C—head—melanoma	0.000784	0.0119	CbGeAlD
Nicardipine—Flushing—Bleomycin—melanoma	0.000773	0.00566	CcSEcCtD
Nicardipine—Body temperature increased—Vemurafenib—melanoma	0.000772	0.00565	CcSEcCtD
Nicardipine—Sinusitis—Temozolomide—melanoma	0.000734	0.00538	CcSEcCtD
Nicardipine—Hypoaesthesia—Carmustine—melanoma	0.000723	0.0053	CcSEcCtD
Nicardipine—Hot flush—Docetaxel—melanoma	0.000722	0.00529	CcSEcCtD
Nicardipine—Flushing—Dactinomycin—melanoma	0.000721	0.00528	CcSEcCtD
Nicardipine—CALM2—mammalian vulva—melanoma	0.000721	0.011	CbGeAlD
Nicardipine—Hypersensitivity—Vemurafenib—melanoma	0.00072	0.00527	CcSEcCtD
Nicardipine—CALM1—mammalian vulva—melanoma	0.000717	0.0109	CbGeAlD
Nicardipine—Oedema peripheral—Carmustine—melanoma	0.000716	0.00525	CcSEcCtD
Nicardipine—Menopausal symptoms—Docetaxel—melanoma	0.000716	0.00524	CcSEcCtD
Nicardipine—Atrial fibrillation—Docetaxel—melanoma	0.000713	0.00522	CcSEcCtD
Nicardipine—Asthenia—Vemurafenib—melanoma	0.000701	0.00513	CcSEcCtD
Nicardipine—Visual impairment—Carmustine—melanoma	0.000701	0.00513	CcSEcCtD
Nicardipine—Hypoaesthesia—Temozolomide—melanoma	0.000699	0.00512	CcSEcCtD
Nicardipine—Oedema peripheral—Temozolomide—melanoma	0.000692	0.00507	CcSEcCtD
Nicardipine—CACNB2—lymph node—melanoma	0.00068	0.0104	CbGeAlD
Nicardipine—ABCB1—blood vessel—melanoma	0.000678	0.0103	CbGeAlD
Nicardipine—Visual impairment—Temozolomide—melanoma	0.000677	0.00496	CcSEcCtD
Nicardipine—Flushing—Carmustine—melanoma	0.000675	0.00494	CcSEcCtD
Nicardipine—Ill-defined disorder—Bleomycin—melanoma	0.000673	0.00493	CcSEcCtD
Nicardipine—Diarrhoea—Vemurafenib—melanoma	0.000668	0.00489	CcSEcCtD
Nicardipine—Tinnitus—Temozolomide—melanoma	0.000655	0.0048	CcSEcCtD
Nicardipine—Malaise—Bleomycin—melanoma	0.000654	0.00479	CcSEcCtD
Nicardipine—Flushing—Temozolomide—melanoma	0.000652	0.00478	CcSEcCtD
Nicardipine—CHRM2—head—melanoma	0.000647	0.00984	CbGeAlD
Nicardipine—Dizziness—Vemurafenib—melanoma	0.000646	0.00473	CcSEcCtD
Nicardipine—CACNA2D1—lymph node—melanoma	0.000639	0.00972	CbGeAlD
Nicardipine—Ill-defined disorder—Dactinomycin—melanoma	0.000627	0.00459	CcSEcCtD
Nicardipine—Vomiting—Vemurafenib—melanoma	0.000621	0.00455	CcSEcCtD
Nicardipine—Chest pain—Bleomycin—melanoma	0.000617	0.00452	CcSEcCtD
Nicardipine—Myalgia—Bleomycin—melanoma	0.000617	0.00452	CcSEcCtD
Nicardipine—Orthostatic hypotension—Docetaxel—melanoma	0.000617	0.00452	CcSEcCtD
Nicardipine—Rash—Vemurafenib—melanoma	0.000616	0.00451	CcSEcCtD
Nicardipine—Dermatitis—Vemurafenib—melanoma	0.000615	0.00451	CcSEcCtD
Nicardipine—Headache—Vemurafenib—melanoma	0.000612	0.00448	CcSEcCtD
Nicardipine—Discomfort—Bleomycin—melanoma	0.00061	0.00447	CcSEcCtD
Nicardipine—Malaise—Dactinomycin—melanoma	0.00061	0.00447	CcSEcCtD
Nicardipine—Confusional state—Bleomycin—melanoma	0.000597	0.00437	CcSEcCtD
Nicardipine—Vision blurred—Carmustine—melanoma	0.000596	0.00437	CcSEcCtD
Nicardipine—CACNA1D—lymph node—melanoma	0.000595	0.00905	CbGeAlD
Nicardipine—Tremor—Carmustine—melanoma	0.000593	0.00434	CcSEcCtD
Nicardipine—Oedema—Bleomycin—melanoma	0.000592	0.00433	CcSEcCtD
Nicardipine—CHRM1—head—melanoma	0.000589	0.00896	CbGeAlD
Nicardipine—Infection—Bleomycin—melanoma	0.000588	0.00431	CcSEcCtD
Nicardipine—CYP2B6—skin of body—melanoma	0.000588	0.00894	CbGeAlD
Nicardipine—Agitation—Carmustine—melanoma	0.000582	0.00426	CcSEcCtD
Nicardipine—Nausea—Vemurafenib—melanoma	0.00058	0.00425	CcSEcCtD
Nicardipine—Thrombocytopenia—Bleomycin—melanoma	0.000579	0.00424	CcSEcCtD
Nicardipine—Vision blurred—Temozolomide—melanoma	0.000576	0.00422	CcSEcCtD
Nicardipine—Myalgia—Dactinomycin—melanoma	0.000576	0.00422	CcSEcCtD
Nicardipine—Tremor—Temozolomide—melanoma	0.000573	0.0042	CcSEcCtD
Nicardipine—Discomfort—Dactinomycin—melanoma	0.000569	0.00417	CcSEcCtD
Nicardipine—Angina pectoris—Docetaxel—melanoma	0.000569	0.00416	CcSEcCtD
Nicardipine—Ill-defined disorder—Temozolomide—melanoma	0.000568	0.00416	CcSEcCtD
Nicardipine—Agitation—Temozolomide—melanoma	0.000562	0.00412	CcSEcCtD
Nicardipine—Hypotension—Bleomycin—melanoma	0.000553	0.00405	CcSEcCtD
Nicardipine—Oedema—Dactinomycin—melanoma	0.000552	0.00404	CcSEcCtD
Nicardipine—Malaise—Temozolomide—melanoma	0.000552	0.00404	CcSEcCtD
Nicardipine—Vertigo—Temozolomide—melanoma	0.00055	0.00402	CcSEcCtD
Nicardipine—CACNA1C—lymph node—melanoma	0.000549	0.00835	CbGeAlD
Nicardipine—Infection—Dactinomycin—melanoma	0.000548	0.00402	CcSEcCtD
Nicardipine—Hypertension—Carmustine—melanoma	0.000546	0.004	CcSEcCtD
Nicardipine—Palpitations—Temozolomide—melanoma	0.000541	0.00396	CcSEcCtD
Nicardipine—Thrombocytopenia—Dactinomycin—melanoma	0.00054	0.00396	CcSEcCtD
Nicardipine—Musculoskeletal discomfort—Bleomycin—melanoma	0.000539	0.00395	CcSEcCtD
Nicardipine—Chest pain—Carmustine—melanoma	0.000539	0.00395	CcSEcCtD
Nicardipine—Myalgia—Carmustine—melanoma	0.000539	0.00395	CcSEcCtD
Nicardipine—Anxiety—Carmustine—melanoma	0.000537	0.00393	CcSEcCtD
Nicardipine—Paraesthesia—Bleomycin—melanoma	0.000531	0.00389	CcSEcCtD
Nicardipine—Hypertension—Temozolomide—melanoma	0.000528	0.00387	CcSEcCtD
Nicardipine—Dyspnoea—Bleomycin—melanoma	0.000528	0.00386	CcSEcCtD
Nicardipine—CHRM3—head—melanoma	0.000527	0.00801	CbGeAlD
Nicardipine—Confusional state—Carmustine—melanoma	0.000521	0.00381	CcSEcCtD
Nicardipine—Myalgia—Temozolomide—melanoma	0.000521	0.00381	CcSEcCtD
Nicardipine—Arthralgia—Temozolomide—melanoma	0.000521	0.00381	CcSEcCtD
Nicardipine—Anxiety—Temozolomide—melanoma	0.000519	0.0038	CcSEcCtD
Nicardipine—Oedema—Carmustine—melanoma	0.000517	0.00378	CcSEcCtD
Nicardipine—CALM2—head—melanoma	0.000516	0.00784	CbGeAlD
Nicardipine—Discomfort—Temozolomide—melanoma	0.000514	0.00377	CcSEcCtD
Nicardipine—CALM1—head—melanoma	0.000513	0.00781	CbGeAlD
Nicardipine—Infection—Carmustine—melanoma	0.000513	0.00376	CcSEcCtD
Nicardipine—Acute coronary syndrome—Docetaxel—melanoma	0.000513	0.00376	CcSEcCtD
Nicardipine—Myocardial infarction—Docetaxel—melanoma	0.00051	0.00374	CcSEcCtD
Nicardipine—Dry mouth—Temozolomide—melanoma	0.000509	0.00373	CcSEcCtD
Nicardipine—Pain—Bleomycin—melanoma	0.000506	0.00371	CcSEcCtD
Nicardipine—Conjunctivitis—Docetaxel—melanoma	0.000506	0.0037	CcSEcCtD
Nicardipine—Thrombocytopenia—Carmustine—melanoma	0.000506	0.0037	CcSEcCtD
Nicardipine—Tachycardia—Carmustine—melanoma	0.000504	0.00369	CcSEcCtD
Nicardipine—Confusional state—Temozolomide—melanoma	0.000503	0.00369	CcSEcCtD
Nicardipine—Musculoskeletal discomfort—Dactinomycin—melanoma	0.000503	0.00368	CcSEcCtD
Nicardipine—Oedema—Temozolomide—melanoma	0.000499	0.00366	CcSEcCtD
Nicardipine—Infection—Temozolomide—melanoma	0.000496	0.00363	CcSEcCtD
Nicardipine—Thrombocytopenia—Temozolomide—melanoma	0.000489	0.00358	CcSEcCtD
Nicardipine—Feeling abnormal—Bleomycin—melanoma	0.000488	0.00357	CcSEcCtD
Nicardipine—ADRA1A—head—melanoma	0.000484	0.00736	CbGeAlD
Nicardipine—Hypotension—Carmustine—melanoma	0.000483	0.00353	CcSEcCtD
Nicardipine—Hyperhidrosis—Temozolomide—melanoma	0.000483	0.00353	CcSEcCtD
Nicardipine—Pain—Dactinomycin—melanoma	0.000472	0.00346	CcSEcCtD
Nicardipine—Musculoskeletal discomfort—Carmustine—melanoma	0.000471	0.00345	CcSEcCtD
Nicardipine—Rhinitis—Docetaxel—melanoma	0.000468	0.00343	CcSEcCtD
Nicardipine—Body temperature increased—Bleomycin—melanoma	0.000468	0.00343	CcSEcCtD
Nicardipine—Insomnia—Carmustine—melanoma	0.000467	0.00342	CcSEcCtD
Nicardipine—Hypoaesthesia—Docetaxel—melanoma	0.000465	0.0034	CcSEcCtD
Nicardipine—Paraesthesia—Carmustine—melanoma	0.000464	0.0034	CcSEcCtD
Nicardipine—Dyspnoea—Carmustine—melanoma	0.000461	0.00337	CcSEcCtD
Nicardipine—Oedema peripheral—Docetaxel—melanoma	0.00046	0.00337	CcSEcCtD
Nicardipine—CALM3—lymph node—melanoma	0.00046	0.00699	CbGeAlD
Nicardipine—Somnolence—Carmustine—melanoma	0.000459	0.00336	CcSEcCtD
Nicardipine—Feeling abnormal—Dactinomycin—melanoma	0.000455	0.00333	CcSEcCtD
Nicardipine—Musculoskeletal discomfort—Temozolomide—melanoma	0.000455	0.00333	CcSEcCtD
Nicardipine—Insomnia—Temozolomide—melanoma	0.000451	0.00331	CcSEcCtD
Nicardipine—Gastrointestinal pain—Dactinomycin—melanoma	0.000451	0.0033	CcSEcCtD
Nicardipine—Visual impairment—Docetaxel—melanoma	0.00045	0.0033	CcSEcCtD
Nicardipine—Paraesthesia—Temozolomide—melanoma	0.000448	0.00328	CcSEcCtD
Nicardipine—Dyspnoea—Temozolomide—melanoma	0.000445	0.00326	CcSEcCtD
Nicardipine—Somnolence—Temozolomide—melanoma	0.000444	0.00325	CcSEcCtD
Nicardipine—Pain—Carmustine—melanoma	0.000442	0.00323	CcSEcCtD
Nicardipine—Constipation—Carmustine—melanoma	0.000442	0.00323	CcSEcCtD
Nicardipine—Dyspepsia—Temozolomide—melanoma	0.000439	0.00322	CcSEcCtD
Nicardipine—Body temperature increased—Dactinomycin—melanoma	0.000436	0.00319	CcSEcCtD
Nicardipine—Abdominal pain—Dactinomycin—melanoma	0.000436	0.00319	CcSEcCtD
Nicardipine—Hypersensitivity—Bleomycin—melanoma	0.000436	0.00319	CcSEcCtD
Nicardipine—Flushing—Docetaxel—melanoma	0.000434	0.00318	CcSEcCtD
Nicardipine—Constipation—Temozolomide—melanoma	0.000427	0.00313	CcSEcCtD
Nicardipine—Pain—Temozolomide—melanoma	0.000427	0.00313	CcSEcCtD
Nicardipine—Feeling abnormal—Carmustine—melanoma	0.000426	0.00312	CcSEcCtD
Nicardipine—Asthenia—Bleomycin—melanoma	0.000425	0.00311	CcSEcCtD
Nicardipine—Gastrointestinal pain—Carmustine—melanoma	0.000422	0.00309	CcSEcCtD
Nicardipine—Feeling abnormal—Temozolomide—melanoma	0.000411	0.00301	CcSEcCtD
Nicardipine—Body temperature increased—Carmustine—melanoma	0.000408	0.00299	CcSEcCtD
Nicardipine—Abdominal pain—Carmustine—melanoma	0.000408	0.00299	CcSEcCtD
Nicardipine—Gastrointestinal pain—Temozolomide—melanoma	0.000408	0.00299	CcSEcCtD
Nicardipine—Hypersensitivity—Dactinomycin—melanoma	0.000407	0.00298	CcSEcCtD
Nicardipine—Asthenia—Dactinomycin—melanoma	0.000396	0.0029	CcSEcCtD
Nicardipine—Abdominal pain—Temozolomide—melanoma	0.000395	0.00289	CcSEcCtD
Nicardipine—Body temperature increased—Temozolomide—melanoma	0.000395	0.00289	CcSEcCtD
Nicardipine—CYP2B6—head—melanoma	0.000383	0.00583	CbGeAlD
Nicardipine—Hypersensitivity—Carmustine—melanoma	0.000381	0.00279	CcSEcCtD
Nicardipine—Diarrhoea—Dactinomycin—melanoma	0.000378	0.00277	CcSEcCtD
Nicardipine—Vomiting—Bleomycin—melanoma	0.000376	0.00276	CcSEcCtD
Nicardipine—Rash—Bleomycin—melanoma	0.000373	0.00273	CcSEcCtD
Nicardipine—Dermatitis—Bleomycin—melanoma	0.000373	0.00273	CcSEcCtD
Nicardipine—Asthenia—Carmustine—melanoma	0.000371	0.00271	CcSEcCtD
Nicardipine—Hypersensitivity—Temozolomide—melanoma	0.000368	0.00269	CcSEcCtD
Nicardipine—Syncope—Docetaxel—melanoma	0.000365	0.00267	CcSEcCtD
Nicardipine—CALM2—lymph node—melanoma	0.000361	0.00549	CbGeAlD
Nicardipine—CYP2E1—head—melanoma	0.00036	0.00547	CbGeAlD
Nicardipine—Palpitations—Docetaxel—melanoma	0.000359	0.00263	CcSEcCtD
Nicardipine—CALM1—lymph node—melanoma	0.000359	0.00547	CbGeAlD
Nicardipine—Asthenia—Temozolomide—melanoma	0.000358	0.00262	CcSEcCtD
Nicardipine—ABCB1—retina—melanoma	0.000358	0.00544	CbGeAlD
Nicardipine—Loss of consciousness—Docetaxel—melanoma	0.000358	0.00262	CcSEcCtD
Nicardipine—Diarrhoea—Carmustine—melanoma	0.000353	0.00259	CcSEcCtD
Nicardipine—Nausea—Bleomycin—melanoma	0.000352	0.00257	CcSEcCtD
Nicardipine—Hypertension—Docetaxel—melanoma	0.000351	0.00257	CcSEcCtD
Nicardipine—Vomiting—Dactinomycin—melanoma	0.000351	0.00257	CcSEcCtD
Nicardipine—Rash—Dactinomycin—melanoma	0.000348	0.00255	CcSEcCtD
Nicardipine—Arthralgia—Docetaxel—melanoma	0.000346	0.00254	CcSEcCtD
Nicardipine—Chest pain—Docetaxel—melanoma	0.000346	0.00254	CcSEcCtD
Nicardipine—Myalgia—Docetaxel—melanoma	0.000346	0.00254	CcSEcCtD
Nicardipine—Dizziness—Carmustine—melanoma	0.000342	0.0025	CcSEcCtD
Nicardipine—Diarrhoea—Temozolomide—melanoma	0.000342	0.0025	CcSEcCtD
Nicardipine—Dry mouth—Docetaxel—melanoma	0.000339	0.00248	CcSEcCtD
Nicardipine—Confusional state—Docetaxel—melanoma	0.000335	0.00245	CcSEcCtD
Nicardipine—Oedema—Docetaxel—melanoma	0.000332	0.00243	CcSEcCtD
Nicardipine—Dizziness—Temozolomide—melanoma	0.00033	0.00242	CcSEcCtD
Nicardipine—Infection—Docetaxel—melanoma	0.00033	0.00242	CcSEcCtD
Nicardipine—Vomiting—Carmustine—melanoma	0.000328	0.00241	CcSEcCtD
Nicardipine—Nausea—Dactinomycin—melanoma	0.000328	0.0024	CcSEcCtD
Nicardipine—Shock—Docetaxel—melanoma	0.000327	0.00239	CcSEcCtD
Nicardipine—Rash—Carmustine—melanoma	0.000326	0.00239	CcSEcCtD
Nicardipine—Dermatitis—Carmustine—melanoma	0.000325	0.00238	CcSEcCtD
Nicardipine—Thrombocytopenia—Docetaxel—melanoma	0.000325	0.00238	CcSEcCtD
Nicardipine—Tachycardia—Docetaxel—melanoma	0.000324	0.00237	CcSEcCtD
Nicardipine—Headache—Carmustine—melanoma	0.000324	0.00237	CcSEcCtD
Nicardipine—Vomiting—Temozolomide—melanoma	0.000317	0.00232	CcSEcCtD
Nicardipine—Rash—Temozolomide—melanoma	0.000315	0.0023	CcSEcCtD
Nicardipine—Dermatitis—Temozolomide—melanoma	0.000314	0.0023	CcSEcCtD
Nicardipine—Headache—Temozolomide—melanoma	0.000313	0.00229	CcSEcCtD
Nicardipine—Hypotension—Docetaxel—melanoma	0.00031	0.00227	CcSEcCtD
Nicardipine—Nausea—Carmustine—melanoma	0.000307	0.00225	CcSEcCtD
Nicardipine—Musculoskeletal discomfort—Docetaxel—melanoma	0.000302	0.00221	CcSEcCtD
Nicardipine—Insomnia—Docetaxel—melanoma	0.0003	0.0022	CcSEcCtD
Nicardipine—Paraesthesia—Docetaxel—melanoma	0.000298	0.00218	CcSEcCtD
Nicardipine—Nausea—Temozolomide—melanoma	0.000297	0.00217	CcSEcCtD
Nicardipine—Dyspnoea—Docetaxel—melanoma	0.000296	0.00217	CcSEcCtD
Nicardipine—Somnolence—Docetaxel—melanoma	0.000295	0.00216	CcSEcCtD
Nicardipine—Dyspepsia—Docetaxel—melanoma	0.000292	0.00214	CcSEcCtD
Nicardipine—ABCB1—mammalian vulva—melanoma	0.000286	0.00436	CbGeAlD
Nicardipine—CYP2D6—head—melanoma	0.000285	0.00433	CbGeAlD
Nicardipine—Constipation—Docetaxel—melanoma	0.000284	0.00208	CcSEcCtD
Nicardipine—Pain—Docetaxel—melanoma	0.000284	0.00208	CcSEcCtD
Nicardipine—Feeling abnormal—Docetaxel—melanoma	0.000274	0.002	CcSEcCtD
Nicardipine—Gastrointestinal pain—Docetaxel—melanoma	0.000271	0.00199	CcSEcCtD
Nicardipine—Abdominal pain—Docetaxel—melanoma	0.000262	0.00192	CcSEcCtD
Nicardipine—Body temperature increased—Docetaxel—melanoma	0.000262	0.00192	CcSEcCtD
Nicardipine—Hypersensitivity—Docetaxel—melanoma	0.000245	0.00179	CcSEcCtD
Nicardipine—Asthenia—Docetaxel—melanoma	0.000238	0.00174	CcSEcCtD
Nicardipine—Diarrhoea—Docetaxel—melanoma	0.000227	0.00166	CcSEcCtD
Nicardipine—Dizziness—Docetaxel—melanoma	0.00022	0.00161	CcSEcCtD
Nicardipine—Vomiting—Docetaxel—melanoma	0.000211	0.00155	CcSEcCtD
Nicardipine—Rash—Docetaxel—melanoma	0.000209	0.00153	CcSEcCtD
Nicardipine—Dermatitis—Docetaxel—melanoma	0.000209	0.00153	CcSEcCtD
Nicardipine—Headache—Docetaxel—melanoma	0.000208	0.00152	CcSEcCtD
Nicardipine—ABCB1—head—melanoma	0.000205	0.00312	CbGeAlD
Nicardipine—Nausea—Docetaxel—melanoma	0.000197	0.00144	CcSEcCtD
Nicardipine—ABCB1—lymph node—melanoma	0.000143	0.00218	CbGeAlD
Nicardipine—Nisoldipine—ABCB1—melanoma	7.29e-05	0.238	CrCbGaD
Nicardipine—Nitrendipine—ABCB1—melanoma	6.82e-05	0.222	CrCbGaD
Nicardipine—Amlodipine—ABCB1—melanoma	5.87e-05	0.192	CrCbGaD
Nicardipine—Felodipine—ABCB1—melanoma	5.43e-05	0.177	CrCbGaD
Nicardipine—Nifedipine—ABCB1—melanoma	5.25e-05	0.171	CrCbGaD
Nicardipine—CALM3—Signaling Pathways—PIK3CB—melanoma	2.93e-06	8.18e-06	CbGpPWpGaD
Nicardipine—CALM1—Metabolism—PTEN—melanoma	2.93e-06	8.17e-06	CbGpPWpGaD
Nicardipine—CALM2—Metabolism—PTEN—melanoma	2.93e-06	8.17e-06	CbGpPWpGaD
Nicardipine—CALM1—Signaling by GPCR—PIK3CA—melanoma	2.93e-06	8.16e-06	CbGpPWpGaD
Nicardipine—CALM2—Signaling by GPCR—PIK3CA—melanoma	2.93e-06	8.16e-06	CbGpPWpGaD
Nicardipine—CHRM2—Signaling by GPCR—AKT1—melanoma	2.92e-06	8.15e-06	CbGpPWpGaD
Nicardipine—ADRA1A—Signaling by GPCR—AKT1—melanoma	2.92e-06	8.13e-06	CbGpPWpGaD
Nicardipine—CALM1—Signaling Pathways—MDM2—melanoma	2.92e-06	8.13e-06	CbGpPWpGaD
Nicardipine—CALM2—Signaling Pathways—MDM2—melanoma	2.92e-06	8.13e-06	CbGpPWpGaD
Nicardipine—CALM2—Immune System—KRAS—melanoma	2.91e-06	8.12e-06	CbGpPWpGaD
Nicardipine—CALM1—Immune System—KRAS—melanoma	2.91e-06	8.12e-06	CbGpPWpGaD
Nicardipine—CALM2—Disease—MYC—melanoma	2.91e-06	8.11e-06	CbGpPWpGaD
Nicardipine—CALM1—Disease—MYC—melanoma	2.91e-06	8.11e-06	CbGpPWpGaD
Nicardipine—ADRA1B—Signaling Pathways—MAPK3—melanoma	2.87e-06	8.02e-06	CbGpPWpGaD
Nicardipine—CALM2—Signaling Pathways—ERBB2—melanoma	2.87e-06	8.02e-06	CbGpPWpGaD
Nicardipine—CALM1—Signaling Pathways—ERBB2—melanoma	2.87e-06	8.02e-06	CbGpPWpGaD
Nicardipine—CYP2D6—Metabolism—PIK3CD—melanoma	2.87e-06	8.01e-06	CbGpPWpGaD
Nicardipine—ADRA1D—Signaling Pathways—PIK3CA—melanoma	2.86e-06	7.98e-06	CbGpPWpGaD
Nicardipine—CYP2C9—Metabolism—PIK3CD—melanoma	2.85e-06	7.94e-06	CbGpPWpGaD
Nicardipine—CALM2—Disease—MAPK1—melanoma	2.85e-06	7.94e-06	CbGpPWpGaD
Nicardipine—CALM1—Disease—MAPK1—melanoma	2.85e-06	7.94e-06	CbGpPWpGaD
Nicardipine—CALM2—Disease—EGFR—melanoma	2.84e-06	7.93e-06	CbGpPWpGaD
Nicardipine—CALM1—Disease—EGFR—melanoma	2.84e-06	7.93e-06	CbGpPWpGaD
Nicardipine—CALM1—Signaling Pathways—PIK3CB—melanoma	2.84e-06	7.91e-06	CbGpPWpGaD
Nicardipine—CALM2—Signaling Pathways—PIK3CB—melanoma	2.84e-06	7.91e-06	CbGpPWpGaD
Nicardipine—CYP2D6—Metabolism—ALB—melanoma	2.84e-06	7.91e-06	CbGpPWpGaD
Nicardipine—CALM3—Signaling Pathways—CXCL8—melanoma	2.82e-06	7.86e-06	CbGpPWpGaD
Nicardipine—CHRM5—Signaling Pathways—HRAS—melanoma	2.81e-06	7.85e-06	CbGpPWpGaD
Nicardipine—CHRM4—Signaling Pathways—IL6—melanoma	2.81e-06	7.84e-06	CbGpPWpGaD
Nicardipine—CYP2C9—Metabolism—ALB—melanoma	2.81e-06	7.84e-06	CbGpPWpGaD
Nicardipine—CALM3—Signaling by GPCR—HRAS—melanoma	2.8e-06	7.81e-06	CbGpPWpGaD
Nicardipine—ADRA1B—Signaling Pathways—MYC—melanoma	2.8e-06	7.8e-06	CbGpPWpGaD
Nicardipine—CALM3—Disease—KRAS—melanoma	2.78e-06	7.75e-06	CbGpPWpGaD
Nicardipine—ADRA1D—Signaling Pathways—TP53—melanoma	2.77e-06	7.72e-06	CbGpPWpGaD
Nicardipine—CALM3—Immune System—PIK3CA—melanoma	2.76e-06	7.71e-06	CbGpPWpGaD
Nicardipine—CALM3—Signaling Pathways—CDKN1B—melanoma	2.75e-06	7.67e-06	CbGpPWpGaD
Nicardipine—CHRM1—Signaling Pathways—VEGFA—melanoma	2.74e-06	7.65e-06	CbGpPWpGaD
Nicardipine—ADRA1B—Signaling Pathways—MAPK1—melanoma	2.74e-06	7.63e-06	CbGpPWpGaD
Nicardipine—ADRA1B—Signaling Pathways—EGFR—melanoma	2.73e-06	7.63e-06	CbGpPWpGaD
Nicardipine—CHRM3—Signaling Pathways—VEGFA—melanoma	2.73e-06	7.62e-06	CbGpPWpGaD
Nicardipine—CYP3A4—Metabolism—PRKCA—melanoma	2.73e-06	7.61e-06	CbGpPWpGaD
Nicardipine—CALM1—Signaling Pathways—CXCL8—melanoma	2.73e-06	7.6e-06	CbGpPWpGaD
Nicardipine—CALM2—Signaling Pathways—CXCL8—melanoma	2.73e-06	7.6e-06	CbGpPWpGaD
Nicardipine—CYP2C19—Metabolism—PIK3CB—melanoma	2.72e-06	7.59e-06	CbGpPWpGaD
Nicardipine—CHRM1—Signaling Pathways—STAT3—melanoma	2.72e-06	7.57e-06	CbGpPWpGaD
Nicardipine—CHRM1—Signaling Pathways—NRAS—melanoma	2.71e-06	7.55e-06	CbGpPWpGaD
Nicardipine—CALM2—Signaling by GPCR—HRAS—melanoma	2.71e-06	7.55e-06	CbGpPWpGaD
Nicardipine—CALM1—Signaling by GPCR—HRAS—melanoma	2.71e-06	7.55e-06	CbGpPWpGaD
Nicardipine—CHRM2—Signaling Pathways—VEGFA—melanoma	2.71e-06	7.55e-06	CbGpPWpGaD
Nicardipine—CHRM3—Signaling Pathways—STAT3—melanoma	2.71e-06	7.55e-06	CbGpPWpGaD
Nicardipine—CYP3A4—Metabolism—ERCC2—melanoma	2.71e-06	7.55e-06	CbGpPWpGaD
Nicardipine—CHRM3—Signaling Pathways—NRAS—melanoma	2.7e-06	7.53e-06	CbGpPWpGaD
Nicardipine—ADRA1A—Signaling Pathways—VEGFA—melanoma	2.7e-06	7.53e-06	CbGpPWpGaD
Nicardipine—CYP2C19—Metabolism—PTGS2—melanoma	2.7e-06	7.52e-06	CbGpPWpGaD
Nicardipine—CALM3—Signaling Pathways—CASP3—melanoma	2.7e-06	7.52e-06	CbGpPWpGaD
Nicardipine—CHRM5—Signaling Pathways—IL6—melanoma	2.69e-06	7.51e-06	CbGpPWpGaD
Nicardipine—CALM3—Signaling Pathways—IL2—melanoma	2.69e-06	7.51e-06	CbGpPWpGaD
Nicardipine—CALM1—Disease—KRAS—melanoma	2.69e-06	7.49e-06	CbGpPWpGaD
Nicardipine—CALM2—Disease—KRAS—melanoma	2.69e-06	7.49e-06	CbGpPWpGaD
Nicardipine—CHRM2—Signaling Pathways—STAT3—melanoma	2.68e-06	7.47e-06	CbGpPWpGaD
Nicardipine—CALM3—Signaling by GPCR—IL6—melanoma	2.68e-06	7.47e-06	CbGpPWpGaD
Nicardipine—CALM2—Immune System—PIK3CA—melanoma	2.67e-06	7.46e-06	CbGpPWpGaD
Nicardipine—CALM1—Immune System—PIK3CA—melanoma	2.67e-06	7.46e-06	CbGpPWpGaD
Nicardipine—CHRM2—Signaling Pathways—NRAS—melanoma	2.67e-06	7.46e-06	CbGpPWpGaD
Nicardipine—ADRA1A—Signaling Pathways—STAT3—melanoma	2.67e-06	7.45e-06	CbGpPWpGaD
Nicardipine—ADRA1A—Signaling Pathways—NRAS—melanoma	2.67e-06	7.44e-06	CbGpPWpGaD
Nicardipine—CALM1—Signaling Pathways—CDKN1B—melanoma	2.66e-06	7.42e-06	CbGpPWpGaD
Nicardipine—CALM2—Signaling Pathways—CDKN1B—melanoma	2.66e-06	7.42e-06	CbGpPWpGaD
Nicardipine—ABCB1—Metabolism—PIK3CB—melanoma	2.66e-06	7.41e-06	CbGpPWpGaD
Nicardipine—ADRA1D—Signaling Pathways—HRAS—melanoma	2.65e-06	7.38e-06	CbGpPWpGaD
Nicardipine—CYP2C8—Metabolism—PTEN—melanoma	2.64e-06	7.35e-06	CbGpPWpGaD
Nicardipine—ABCB1—Metabolism—PTGS2—melanoma	2.63e-06	7.34e-06	CbGpPWpGaD
Nicardipine—CALM3—Signaling Pathways—CCND1—melanoma	2.63e-06	7.32e-06	CbGpPWpGaD
Nicardipine—CALM2—Signaling Pathways—CASP3—melanoma	2.61e-06	7.28e-06	CbGpPWpGaD
Nicardipine—CALM1—Signaling Pathways—CASP3—melanoma	2.61e-06	7.28e-06	CbGpPWpGaD
Nicardipine—CALM1—Signaling Pathways—IL2—melanoma	2.6e-06	7.26e-06	CbGpPWpGaD
Nicardipine—CALM2—Signaling Pathways—IL2—melanoma	2.6e-06	7.26e-06	CbGpPWpGaD
Nicardipine—CALM3—Signaling Pathways—CTNNB1—melanoma	2.6e-06	7.25e-06	CbGpPWpGaD
Nicardipine—CHRM4—Signaling Pathways—AKT1—melanoma	2.59e-06	7.24e-06	CbGpPWpGaD
Nicardipine—CHRM1—Signaling Pathways—MAPK3—melanoma	2.59e-06	7.23e-06	CbGpPWpGaD
Nicardipine—CALM2—Signaling by GPCR—IL6—melanoma	2.59e-06	7.23e-06	CbGpPWpGaD
Nicardipine—CALM1—Signaling by GPCR—IL6—melanoma	2.59e-06	7.23e-06	CbGpPWpGaD
Nicardipine—CHRM3—Signaling Pathways—MAPK3—melanoma	2.59e-06	7.21e-06	CbGpPWpGaD
Nicardipine—ADRA1B—Signaling Pathways—KRAS—melanoma	2.58e-06	7.21e-06	CbGpPWpGaD
Nicardipine—CHRM2—Signaling Pathways—MAPK3—melanoma	2.56e-06	7.14e-06	CbGpPWpGaD
Nicardipine—CALM3—Immune System—HRAS—melanoma	2.56e-06	7.13e-06	CbGpPWpGaD
Nicardipine—ADRA1A—Signaling Pathways—MAPK3—melanoma	2.55e-06	7.12e-06	CbGpPWpGaD
Nicardipine—CHRM3—Metabolism—PIK3CA—melanoma	2.55e-06	7.12e-06	CbGpPWpGaD
Nicardipine—CALM3—Disease—PIK3CA—melanoma	2.55e-06	7.12e-06	CbGpPWpGaD
Nicardipine—CALM3—Signaling Pathways—MMP9—melanoma	2.55e-06	7.11e-06	CbGpPWpGaD
Nicardipine—CALM3—Signaling Pathways—CDKN1A—melanoma	2.54e-06	7.08e-06	CbGpPWpGaD
Nicardipine—CALM1—Signaling Pathways—CCND1—melanoma	2.54e-06	7.08e-06	CbGpPWpGaD
Nicardipine—CALM2—Signaling Pathways—CCND1—melanoma	2.54e-06	7.08e-06	CbGpPWpGaD
Nicardipine—CALM3—Signaling Pathways—PTEN—melanoma	2.53e-06	7.07e-06	CbGpPWpGaD
Nicardipine—ADRA1D—Signaling Pathways—IL6—melanoma	2.53e-06	7.06e-06	CbGpPWpGaD
Nicardipine—CHRM1—Signaling Pathways—MYC—melanoma	2.52e-06	7.04e-06	CbGpPWpGaD
Nicardipine—CALM3—Signaling Pathways—NFKB1—melanoma	2.52e-06	7.03e-06	CbGpPWpGaD
Nicardipine—CHRM3—Signaling Pathways—MYC—melanoma	2.51e-06	7.01e-06	CbGpPWpGaD
Nicardipine—CALM1—Signaling Pathways—CTNNB1—melanoma	2.51e-06	7.01e-06	CbGpPWpGaD
Nicardipine—CALM2—Signaling Pathways—CTNNB1—melanoma	2.51e-06	7.01e-06	CbGpPWpGaD
Nicardipine—CYP2D6—Metabolism—PIK3CB—melanoma	2.5e-06	6.98e-06	CbGpPWpGaD
Nicardipine—CHRM2—Signaling Pathways—MYC—melanoma	2.49e-06	6.95e-06	CbGpPWpGaD
Nicardipine—CHRM5—Signaling Pathways—AKT1—melanoma	2.48e-06	6.93e-06	CbGpPWpGaD
Nicardipine—ADRA1A—Signaling Pathways—MYC—melanoma	2.48e-06	6.93e-06	CbGpPWpGaD
Nicardipine—CYP2C9—Metabolism—PIK3CB—melanoma	2.48e-06	6.92e-06	CbGpPWpGaD
Nicardipine—CYP2D6—Metabolism—PTGS2—melanoma	2.48e-06	6.92e-06	CbGpPWpGaD
Nicardipine—CALM1—Immune System—HRAS—melanoma	2.47e-06	6.9e-06	CbGpPWpGaD
Nicardipine—CALM2—Immune System—HRAS—melanoma	2.47e-06	6.9e-06	CbGpPWpGaD
Nicardipine—CALM3—Signaling by GPCR—AKT1—melanoma	2.47e-06	6.89e-06	CbGpPWpGaD
Nicardipine—CALM2—Disease—PIK3CA—melanoma	2.47e-06	6.89e-06	CbGpPWpGaD
Nicardipine—CALM1—Disease—PIK3CA—melanoma	2.47e-06	6.89e-06	CbGpPWpGaD
Nicardipine—CHRM1—Signaling Pathways—MAPK1—melanoma	2.47e-06	6.88e-06	CbGpPWpGaD
Nicardipine—CHRM1—Signaling Pathways—EGFR—melanoma	2.47e-06	6.88e-06	CbGpPWpGaD
Nicardipine—CALM2—Signaling Pathways—MMP9—melanoma	2.47e-06	6.88e-06	CbGpPWpGaD
Nicardipine—CALM1—Signaling Pathways—MMP9—melanoma	2.47e-06	6.88e-06	CbGpPWpGaD
Nicardipine—CHRM3—Signaling Pathways—MAPK1—melanoma	2.46e-06	6.86e-06	CbGpPWpGaD
Nicardipine—CYP2C9—Metabolism—PTGS2—melanoma	2.46e-06	6.86e-06	CbGpPWpGaD
Nicardipine—CHRM3—Signaling Pathways—EGFR—melanoma	2.46e-06	6.86e-06	CbGpPWpGaD
Nicardipine—CALM1—Signaling Pathways—CDKN1A—melanoma	2.46e-06	6.85e-06	CbGpPWpGaD
Nicardipine—CALM2—Signaling Pathways—CDKN1A—melanoma	2.46e-06	6.85e-06	CbGpPWpGaD
Nicardipine—CALM2—Signaling Pathways—PTEN—melanoma	2.45e-06	6.84e-06	CbGpPWpGaD
Nicardipine—CALM1—Signaling Pathways—PTEN—melanoma	2.45e-06	6.84e-06	CbGpPWpGaD
Nicardipine—CALM3—Immune System—IL6—melanoma	2.45e-06	6.83e-06	CbGpPWpGaD
Nicardipine—CALM2—Signaling Pathways—NFKB1—melanoma	2.44e-06	6.8e-06	CbGpPWpGaD
Nicardipine—CALM1—Signaling Pathways—NFKB1—melanoma	2.44e-06	6.8e-06	CbGpPWpGaD
Nicardipine—CHRM2—Signaling Pathways—MAPK1—melanoma	2.44e-06	6.79e-06	CbGpPWpGaD
Nicardipine—CHRM2—Signaling Pathways—EGFR—melanoma	2.44e-06	6.79e-06	CbGpPWpGaD
Nicardipine—ADRA1A—Signaling Pathways—MAPK1—melanoma	2.43e-06	6.78e-06	CbGpPWpGaD
Nicardipine—ADRA1A—Signaling Pathways—EGFR—melanoma	2.43e-06	6.77e-06	CbGpPWpGaD
Nicardipine—CALM1—Signaling by GPCR—AKT1—melanoma	2.39e-06	6.67e-06	CbGpPWpGaD
Nicardipine—CALM2—Signaling by GPCR—AKT1—melanoma	2.39e-06	6.67e-06	CbGpPWpGaD
Nicardipine—ADRA1B—Signaling Pathways—PIK3CA—melanoma	2.37e-06	6.62e-06	CbGpPWpGaD
Nicardipine—CALM2—Immune System—IL6—melanoma	2.37e-06	6.6e-06	CbGpPWpGaD
Nicardipine—CALM1—Immune System—IL6—melanoma	2.37e-06	6.6e-06	CbGpPWpGaD
Nicardipine—CALM3—Disease—HRAS—melanoma	2.36e-06	6.59e-06	CbGpPWpGaD
Nicardipine—CYP2C19—Metabolism—PTEN—melanoma	2.35e-06	6.56e-06	CbGpPWpGaD
Nicardipine—ADRA1D—Signaling Pathways—AKT1—melanoma	2.34e-06	6.52e-06	CbGpPWpGaD
Nicardipine—CHRM1—Signaling Pathways—KRAS—melanoma	2.33e-06	6.5e-06	CbGpPWpGaD
Nicardipine—CHRM3—Signaling Pathways—KRAS—melanoma	2.32e-06	6.48e-06	CbGpPWpGaD
Nicardipine—CHRM2—Signaling Pathways—KRAS—melanoma	2.3e-06	6.42e-06	CbGpPWpGaD
Nicardipine—ABCB1—Metabolism—PTEN—melanoma	2.3e-06	6.4e-06	CbGpPWpGaD
Nicardipine—ADRA1B—Signaling Pathways—TP53—melanoma	2.3e-06	6.4e-06	CbGpPWpGaD
Nicardipine—ADRA1A—Signaling Pathways—KRAS—melanoma	2.29e-06	6.4e-06	CbGpPWpGaD
Nicardipine—CALM3—Signaling Pathways—VEGFA—melanoma	2.29e-06	6.38e-06	CbGpPWpGaD
Nicardipine—CALM1—Disease—HRAS—melanoma	2.28e-06	6.37e-06	CbGpPWpGaD
Nicardipine—CALM2—Disease—HRAS—melanoma	2.28e-06	6.37e-06	CbGpPWpGaD
Nicardipine—CALM3—Signaling Pathways—STAT3—melanoma	2.27e-06	6.32e-06	CbGpPWpGaD
Nicardipine—CALM3—Signaling Pathways—NRAS—melanoma	2.26e-06	6.3e-06	CbGpPWpGaD
Nicardipine—CALM3—Disease—IL6—melanoma	2.26e-06	6.3e-06	CbGpPWpGaD
Nicardipine—CALM3—Immune System—AKT1—melanoma	2.26e-06	6.3e-06	CbGpPWpGaD
Nicardipine—CALM2—Signaling Pathways—VEGFA—melanoma	2.21e-06	6.17e-06	CbGpPWpGaD
Nicardipine—CALM1—Signaling Pathways—VEGFA—melanoma	2.21e-06	6.17e-06	CbGpPWpGaD
Nicardipine—CYP2B6—Metabolism—PIK3CA—melanoma	2.2e-06	6.13e-06	CbGpPWpGaD
Nicardipine—ADRA1B—Signaling Pathways—HRAS—melanoma	2.2e-06	6.12e-06	CbGpPWpGaD
Nicardipine—CALM2—Signaling Pathways—STAT3—melanoma	2.19e-06	6.11e-06	CbGpPWpGaD
Nicardipine—CALM1—Signaling Pathways—STAT3—melanoma	2.19e-06	6.11e-06	CbGpPWpGaD
Nicardipine—CALM2—Signaling Pathways—NRAS—melanoma	2.19e-06	6.1e-06	CbGpPWpGaD
Nicardipine—CALM1—Signaling Pathways—NRAS—melanoma	2.19e-06	6.1e-06	CbGpPWpGaD
Nicardipine—CALM2—Disease—IL6—melanoma	2.19e-06	6.1e-06	CbGpPWpGaD
Nicardipine—CALM1—Disease—IL6—melanoma	2.19e-06	6.1e-06	CbGpPWpGaD
Nicardipine—CALM2—Immune System—AKT1—melanoma	2.18e-06	6.09e-06	CbGpPWpGaD
Nicardipine—CALM1—Immune System—AKT1—melanoma	2.18e-06	6.09e-06	CbGpPWpGaD
Nicardipine—CALM3—Signaling Pathways—MAPK3—melanoma	2.16e-06	6.04e-06	CbGpPWpGaD
Nicardipine—CYP2D6—Metabolism—PTEN—melanoma	2.16e-06	6.03e-06	CbGpPWpGaD
Nicardipine—CYP2E1—Metabolism—PIK3CA—melanoma	2.15e-06	6e-06	CbGpPWpGaD
Nicardipine—CYP3A5—Metabolism—PIK3CA—melanoma	2.15e-06	5.99e-06	CbGpPWpGaD
Nicardipine—CYP2C9—Metabolism—PTEN—melanoma	2.15e-06	5.98e-06	CbGpPWpGaD
Nicardipine—CHRM1—Signaling Pathways—PIK3CA—melanoma	2.14e-06	5.97e-06	CbGpPWpGaD
Nicardipine—CALM3—Metabolism—PIK3CA—melanoma	2.14e-06	5.96e-06	CbGpPWpGaD
Nicardipine—CYP3A4—Metabolism—PIK3CG—melanoma	2.14e-06	5.96e-06	CbGpPWpGaD
Nicardipine—CHRM3—Signaling Pathways—PIK3CA—melanoma	2.13e-06	5.95e-06	CbGpPWpGaD
Nicardipine—CHRM2—Signaling Pathways—PIK3CA—melanoma	2.11e-06	5.9e-06	CbGpPWpGaD
Nicardipine—ADRA1A—Signaling Pathways—PIK3CA—melanoma	2.11e-06	5.88e-06	CbGpPWpGaD
Nicardipine—CALM3—Signaling Pathways—MYC—melanoma	2.11e-06	5.87e-06	CbGpPWpGaD
Nicardipine—ADRA1B—Signaling Pathways—IL6—melanoma	2.1e-06	5.86e-06	CbGpPWpGaD
Nicardipine—CALM2—Signaling Pathways—MAPK3—melanoma	2.09e-06	5.84e-06	CbGpPWpGaD
Nicardipine—CALM1—Signaling Pathways—MAPK3—melanoma	2.09e-06	5.84e-06	CbGpPWpGaD
Nicardipine—CHRM3—Metabolism—AKT1—melanoma	2.09e-06	5.82e-06	CbGpPWpGaD
Nicardipine—CALM3—Disease—AKT1—melanoma	2.09e-06	5.82e-06	CbGpPWpGaD
Nicardipine—CHRM1—Signaling Pathways—TP53—melanoma	2.07e-06	5.78e-06	CbGpPWpGaD
Nicardipine—CALM1—Metabolism—PIK3CA—melanoma	2.07e-06	5.77e-06	CbGpPWpGaD
Nicardipine—CALM2—Metabolism—PIK3CA—melanoma	2.07e-06	5.77e-06	CbGpPWpGaD
Nicardipine—CHRM3—Signaling Pathways—TP53—melanoma	2.07e-06	5.76e-06	CbGpPWpGaD
Nicardipine—CYP3A4—Metabolism—PPARG—melanoma	2.06e-06	5.75e-06	CbGpPWpGaD
Nicardipine—CALM3—Signaling Pathways—MAPK1—melanoma	2.06e-06	5.74e-06	CbGpPWpGaD
Nicardipine—CALM3—Signaling Pathways—EGFR—melanoma	2.06e-06	5.74e-06	CbGpPWpGaD
Nicardipine—CHRM2—Signaling Pathways—TP53—melanoma	2.05e-06	5.7e-06	CbGpPWpGaD
Nicardipine—ADRA1A—Signaling Pathways—TP53—melanoma	2.04e-06	5.69e-06	CbGpPWpGaD
Nicardipine—CALM1—Signaling Pathways—MYC—melanoma	2.04e-06	5.68e-06	CbGpPWpGaD
Nicardipine—CALM2—Signaling Pathways—MYC—melanoma	2.04e-06	5.68e-06	CbGpPWpGaD
Nicardipine—CALM2—Disease—AKT1—melanoma	2.02e-06	5.63e-06	CbGpPWpGaD
Nicardipine—CALM1—Disease—AKT1—melanoma	2.02e-06	5.63e-06	CbGpPWpGaD
Nicardipine—CALM2—Signaling Pathways—MAPK1—melanoma	1.99e-06	5.56e-06	CbGpPWpGaD
Nicardipine—CALM1—Signaling Pathways—MAPK1—melanoma	1.99e-06	5.56e-06	CbGpPWpGaD
Nicardipine—CALM2—Signaling Pathways—EGFR—melanoma	1.99e-06	5.56e-06	CbGpPWpGaD
Nicardipine—CALM1—Signaling Pathways—EGFR—melanoma	1.99e-06	5.56e-06	CbGpPWpGaD
Nicardipine—CHRM1—Signaling Pathways—HRAS—melanoma	1.98e-06	5.53e-06	CbGpPWpGaD
Nicardipine—CHRM3—Signaling Pathways—HRAS—melanoma	1.98e-06	5.51e-06	CbGpPWpGaD
Nicardipine—CHRM2—Signaling Pathways—HRAS—melanoma	1.96e-06	5.45e-06	CbGpPWpGaD
Nicardipine—ADRA1A—Signaling Pathways—HRAS—melanoma	1.95e-06	5.44e-06	CbGpPWpGaD
Nicardipine—CALM3—Signaling Pathways—KRAS—melanoma	1.95e-06	5.43e-06	CbGpPWpGaD
Nicardipine—ADRA1B—Signaling Pathways—AKT1—melanoma	1.94e-06	5.41e-06	CbGpPWpGaD
Nicardipine—CHRM1—Signaling Pathways—IL6—melanoma	1.9e-06	5.29e-06	CbGpPWpGaD
Nicardipine—CHRM3—Signaling Pathways—IL6—melanoma	1.89e-06	5.27e-06	CbGpPWpGaD
Nicardipine—CALM2—Signaling Pathways—KRAS—melanoma	1.88e-06	5.25e-06	CbGpPWpGaD
Nicardipine—CALM1—Signaling Pathways—KRAS—melanoma	1.88e-06	5.25e-06	CbGpPWpGaD
Nicardipine—CYP3A4—Metabolism—PIK3CD—melanoma	1.88e-06	5.24e-06	CbGpPWpGaD
Nicardipine—CHRM2—Signaling Pathways—IL6—melanoma	1.87e-06	5.22e-06	CbGpPWpGaD
Nicardipine—ADRA1A—Signaling Pathways—IL6—melanoma	1.87e-06	5.21e-06	CbGpPWpGaD
Nicardipine—CYP2C8—Metabolism—PIK3CA—melanoma	1.86e-06	5.19e-06	CbGpPWpGaD
Nicardipine—CYP3A4—Metabolism—ALB—melanoma	1.85e-06	5.17e-06	CbGpPWpGaD
Nicardipine—CYP2B6—Metabolism—AKT1—melanoma	1.79e-06	5e-06	CbGpPWpGaD
Nicardipine—CALM3—Signaling Pathways—PIK3CA—melanoma	1.79e-06	4.98e-06	CbGpPWpGaD
Nicardipine—CYP2E1—Metabolism—AKT1—melanoma	1.76e-06	4.9e-06	CbGpPWpGaD
Nicardipine—CYP3A5—Metabolism—AKT1—melanoma	1.75e-06	4.89e-06	CbGpPWpGaD
Nicardipine—CHRM1—Signaling Pathways—AKT1—melanoma	1.75e-06	4.88e-06	CbGpPWpGaD
Nicardipine—CALM3—Metabolism—AKT1—melanoma	1.75e-06	4.87e-06	CbGpPWpGaD
Nicardipine—CHRM3—Signaling Pathways—AKT1—melanoma	1.74e-06	4.86e-06	CbGpPWpGaD
Nicardipine—CALM3—Signaling Pathways—TP53—melanoma	1.73e-06	4.82e-06	CbGpPWpGaD
Nicardipine—CALM1—Signaling Pathways—PIK3CA—melanoma	1.73e-06	4.82e-06	CbGpPWpGaD
Nicardipine—CALM2—Signaling Pathways—PIK3CA—melanoma	1.73e-06	4.82e-06	CbGpPWpGaD
Nicardipine—CHRM2—Signaling Pathways—AKT1—melanoma	1.73e-06	4.82e-06	CbGpPWpGaD
Nicardipine—ADRA1A—Signaling Pathways—AKT1—melanoma	1.72e-06	4.8e-06	CbGpPWpGaD
Nicardipine—CALM1—Metabolism—AKT1—melanoma	1.69e-06	4.71e-06	CbGpPWpGaD
Nicardipine—CALM2—Metabolism—AKT1—melanoma	1.69e-06	4.71e-06	CbGpPWpGaD
Nicardipine—CALM1—Signaling Pathways—TP53—melanoma	1.67e-06	4.66e-06	CbGpPWpGaD
Nicardipine—CALM2—Signaling Pathways—TP53—melanoma	1.67e-06	4.66e-06	CbGpPWpGaD
Nicardipine—CYP2C19—Metabolism—PIK3CA—melanoma	1.66e-06	4.63e-06	CbGpPWpGaD
Nicardipine—CALM3—Signaling Pathways—HRAS—melanoma	1.65e-06	4.61e-06	CbGpPWpGaD
Nicardipine—CYP3A4—Metabolism—PIK3CB—melanoma	1.64e-06	4.57e-06	CbGpPWpGaD
Nicardipine—CYP3A4—Metabolism—PTGS2—melanoma	1.62e-06	4.52e-06	CbGpPWpGaD
Nicardipine—ABCB1—Metabolism—PIK3CA—melanoma	1.62e-06	4.52e-06	CbGpPWpGaD
Nicardipine—CALM2—Signaling Pathways—HRAS—melanoma	1.6e-06	4.46e-06	CbGpPWpGaD
Nicardipine—CALM1—Signaling Pathways—HRAS—melanoma	1.6e-06	4.46e-06	CbGpPWpGaD
Nicardipine—CALM3—Signaling Pathways—IL6—melanoma	1.58e-06	4.41e-06	CbGpPWpGaD
Nicardipine—CALM2—Signaling Pathways—IL6—melanoma	1.53e-06	4.27e-06	CbGpPWpGaD
Nicardipine—CALM1—Signaling Pathways—IL6—melanoma	1.53e-06	4.27e-06	CbGpPWpGaD
Nicardipine—CYP2D6—Metabolism—PIK3CA—melanoma	1.53e-06	4.26e-06	CbGpPWpGaD
Nicardipine—CYP2C8—Metabolism—AKT1—melanoma	1.52e-06	4.24e-06	CbGpPWpGaD
Nicardipine—CYP2C9—Metabolism—PIK3CA—melanoma	1.51e-06	4.22e-06	CbGpPWpGaD
Nicardipine—CALM3—Signaling Pathways—AKT1—melanoma	1.46e-06	4.07e-06	CbGpPWpGaD
Nicardipine—CYP3A4—Metabolism—PTEN—melanoma	1.41e-06	3.95e-06	CbGpPWpGaD
Nicardipine—CALM2—Signaling Pathways—AKT1—melanoma	1.41e-06	3.94e-06	CbGpPWpGaD
Nicardipine—CALM1—Signaling Pathways—AKT1—melanoma	1.41e-06	3.94e-06	CbGpPWpGaD
Nicardipine—CYP2C19—Metabolism—AKT1—melanoma	1.36e-06	3.78e-06	CbGpPWpGaD
Nicardipine—ABCB1—Metabolism—AKT1—melanoma	1.32e-06	3.69e-06	CbGpPWpGaD
Nicardipine—CYP2D6—Metabolism—AKT1—melanoma	1.25e-06	3.48e-06	CbGpPWpGaD
Nicardipine—CYP2C9—Metabolism—AKT1—melanoma	1.24e-06	3.45e-06	CbGpPWpGaD
Nicardipine—CYP3A4—Metabolism—PIK3CA—melanoma	9.98e-07	2.78e-06	CbGpPWpGaD
Nicardipine—CYP3A4—Metabolism—AKT1—melanoma	8.15e-07	2.27e-06	CbGpPWpGaD
